MARGINAL ZONE B CELL LYMPHOMA
Clinical trials for MARGINAL ZONE B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for MARGINAL ZONE B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart blood pressure cuffs could protect cancer patients from heart risks
Disease control Not yet recruitingThis pilot study tests whether a connected blood pressure monitor, supervised daily by a healthcare assistant, helps patients with blood cancers like CLL or lymphoma stick to home monitoring. The goal is to catch and manage high blood pressure early, a common side effect of BTK i…
Matched conditions: MARGINAL ZONE B CELL LYMPHOMA
Phase: NA • Sponsor: Centre Hospitalier de la côte Basque • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New injection shows promise for Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called JL19001 in people with advanced solid tumors or a type of lymphoma that has come back or not responded to treatment. The main goal is to find a safe dose and check for side effects. About 14 participants will receive the drug as a sh…
Matched conditions: MARGINAL ZONE B CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC